Colds and flu boost Reckitt Benckiser
Revenues climbed by 7% to £2.52bn in the first three months of this year compared with the same period a year earlier, Reckitt said in a trading update.
The London-listed group added that its performance was boosted by strong over-the-counter sales of Mucinex decongestant medicine and Strepsils throat lozenges.
"We are pleased with a strong start to the year, with our health and hygiene brands leading Reckitt Benckiser's growth across all geographies," said chief executive Rakesh Kapoor.
He added: "Mucinex and Strepsils have done particularly well, benefitting from a higher incidence of flu in the United States."
Kapoor said that the group experienced solid sales of Dettol surface cleaners, Durex condoms and Nurofen pain relief pills.
The British-based company cautioned over challenging market conditions but remained "confident" that it would achieve annual revenue growth of between 5.0% and 6.0%.
Reckitt had bought US-based Schiff Nutrition for US$1.4bn last year in a move which strengthened its position in the consumer health sector.
Reckitt's other key brands also include Air Wick air fresheners, Finish dishwasher tablets and Harpic toilet cleaners.
Source: AFP via I-Netbridge
Source: I-Net Bridge
For more than two decades, I-Net Bridge has been one of South Africa’s preferred electronic providers of innovative solutions, data of the highest calibre, reliable platforms and excellent supporting systems. Our products include workstations, web applications and data feeds packaged with in-depth news and powerful analytical tools empowering clients to make meaningful decisions.
We pride ourselves on our wide variety of in-house skills, encompassing multiple platforms and applications. These skills enable us to not only function as a first class facility, but also design, implement and support all our client needs at a level that confirms I-Net Bridge a leader in its field.
Go to: http://www.inet.co.za
